Reynoso Jamie L. 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jul 6, 2026
Research Summary
AI-generated summary of this filing
Clover Health (CLOV) CEO Jamie L. Reynoso Sells 6,229 Shares
What Happened Jamie L. Reynoso, CEO (Medicare Advantage) of Clover Health Investments, sold 6,229 shares of Class A common stock on July 6, 2026, at $5.26 per share, for proceeds of $32,765. This was a sale (not a purchase) and reflects a routine sell-to-cover to satisfy tax withholding on vested restricted stock units (RSUs), not a discretionary trade.
Key Details
- Transaction type: Open market/private sale (Code S) on 2026-07-06 at $5.26 per share. Total reported proceeds: $32,765.
- Period of report / filing: Transaction relates to RSU vesting on 2026-07-03; Form 4 filed 2026-07-06 (appears timely).
- Shares owned after transaction: Not disclosed in the supplied filing details.
- Footnote: The sale was required to cover tax withholding on 6.25% of RSUs that vested July 3, 2026. The RSUs were granted January 3, 2023; remaining RSUs vest quarterly (6.25% each) with final vesting on January 1, 2027, subject to continued service. The issuer’s equity plan mandates "sell to cover" funding for withholding (footnote F1).
- Not a 10b5-1 plan or option exercise; proceeds reflect tax withholding only, per the filing.
Context Sell-to-cover transactions are common when RSUs vest and generally reflect tax obligations rather than a deliberate decision to liquidate holdings. Such routine withholding sales are less informative about the insider’s market views than outright discretionary purchases.
Insider Transaction Report
- Sale
Class A Common Stock
[F1]2026-07-06$5.26/sh−6,229$32,765→ 2,834,982 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.